Gene therapy for head and neck cancer, and clinical trials in head and neck cancer.
Head and Neck Oncology- Melanoma/Skin
HealthLeaders Oncologists expect patients to get a second opinion when they are diagnosed with cancer; it's best practice. According to George Yoo, M.D., FACS , chief medical officer (CMO) at Karmanos Cancer Hospital, a second opinion can confirm a diagnosis and treatment plan, or it can change one or the other. Regardless, second opinions can help reassure patients that they are making the right choice for their care. Dr. Yoo explained how Karmanos can get cancer patients seeking a second opinion in fo...
Castle Connolly’s 2025 Top Doctors list has been announced, with 18 Barbara Ann Karmanos Cancer Institute physicians listed. There are about 1 million practicing physicians in the U.S. Castle Connolly’s list includes over 70,000 physicians, the top 7% of physicians across the country, all board-certified in 85 medical specialties. Selection for the Top Doctors list is based on peer nominations (over 39,000 nominations were submitted in 2024), professional achievements, and excellence in patient care. A ...
Becker's Hospital Review George Yoo, M.D., FACS , chief medical officer (CMO) at Karmanos Cancer Hospital, was again listed on Becker’s Hospital Review’s Chief Medical Officers to Know. The 2025 list includes over 180 CMOs nationwide who “play a pivotal role in advancing patient safety, maintaining high-quality standards, bridging the gap between leadership and medical staff, and managing risk.” The CMOs named are leaders who are continually driven for improvement, leading to multiple quality and safety...